Indium-111 Pentetreotide

DB17335ApprovedWithdrawnSmall moleculeRadioactive Diagnostic Agent

Indium-111 Pentetreotide: Overview.

Resolves to

Compound
UNIIM312JJ6Z32CAS139096-04-1

What you can answer from here — as of November 06, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Indium-111 Pentetreotide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In